We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

62 hedge funds and large institutions have $1.37B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

7% more funds holding

Funds holding: 58 → 62 (+4)

15% less capital invested

Capital invested by funds: $1.61B → $1.37B (-$234M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
15
Increased
23
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
2
State Street
State Street
Massachusetts
+$13.6M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$11.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.7M
5
WP
Woodline Partners
California
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$11.4M
2
BC
Boxer Capital
California
-$8.78M
3
EC
EcoR1 Capital
California
-$6.63M
4
DM
Deerfield Management
New York
-$6.38M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
26
Verition Fund Management
Connecticut
$3.59M +$3.31M +226,074 +638%
GL
27
Governors Lane
New York
$2.62M – – –
Goldman Sachs
28
Goldman Sachs
New York
$2.61M +$2.37M +161,957 +572%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$2.58M +$2.43M +165,788 +737%
Charles Schwab
30
Charles Schwab
California
$2.36M +$72.6K +4,960 +3%
LCP
31
LGT Capital Partners
Switzerland
$1.98M – – –
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.57M +$1.13M +77,557 +209%
Citigroup
33
Citigroup
New York
$1.43M +$183K +12,530 +14%
ECM
34
ExodusPoint Capital Management
New York
$1.21M +$558K +38,100 +76%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$1M – – –
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$977K +$1.04M +71,159 New
Northern Trust
37
Northern Trust
Illinois
$956K +$55.5K +3,796 +6%
HighTower Advisors
38
HighTower Advisors
Illinois
$914K +$310K +21,219 +47%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$846K +$901K +61,585 New
MWNA
40
Marshall Wace North America
New York
$667K -$2.12M -145,219 -75%
HF
41
HRT Financial
New York
$458K +$488K +33,368 New
BC
42
Brookfield Corp
Ontario, Canada
$333K -$177K -12,102 -33%
Marshall Wace
43
Marshall Wace
United Kingdom
$324K -$646K -44,175 -65%
LP
44
LMR Partners
United Kingdom
$304K +$324K +22,145 New
Bank of America
45
Bank of America
North Carolina
$206K +$219K +14,958 +31,163%
PCM
46
Penserra Capital Management
California
$202K -$102K -6,939 -32%
Man Group
47
Man Group
United Kingdom
$185K +$197K +13,468 New
CS
48
Credit Suisse
Switzerland
$178K +$189K +12,947 New
SSA
49
Schonfeld Strategic Advisors
New York
$178K +$190K +13,002 New
IWC
50
Integrated Wealth Concepts
Massachusetts
$165K +$176K +12,050 New
1
2
3

CERE Hedge Fund Activity: Q1 2021 in Review

62 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q1 2021, worth a combined $1.37B — down 15% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CERE positions and 11 closed out — a net gain of 4 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Federated Hermes, adding an estimated $14.6M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $11.4M sold.

  • 62 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q1 2021, up from 58 in Q4 2020.
  • Funds reported $1.37B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q1 2021, down 15% quarter-over-quarter.
  • 15 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q1 2021 and 11 closed out, a net change of +4 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q1 2021 was Federated Hermes, an estimated $14.6M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q1 2021 was Nantahala Capital Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q1 2021.